{"nct_id":"NCT01051349","title":"Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2018-04","start_date":"2010-03-31","start_date_type":"ACTUAL","primary_completion_date":"2016-08-25","primary_completion_date_type":"ACTUAL","completion_date":"2016-08-25","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BIIB"]}